Uwe Wagner - Concepedia

Author

Uwe Wagner

Also Known As

G. Cormio, R Dittmeyer, U Wagner, U. A. Wagner, U. WAGNER, U. Wagner, U. Wagner, UWE WAGNER, Uwe A. G. Wagner, Uwe Wagner

542

Publications

9.4K

Citations

H-Index

173

Concepts

All Affiliations

Philipps University of Marburg Universitätsklinikum Gießen und Marburg University of Bonn Heinrich Heine University Düsseldorf Institute of Molecular Biology

About

Uwe Wagner is an author at Philipps University of Marburg specializing in medicine, oncology, and ovarian cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	10	10	532
2	Health Sciences	9	9	371
3	Business	3	3	47
4	Education	3	3	243
5	Management	2	2	35

Uwe Wagner

120

Publications

8.1K

Citations

H-Index

Page 1

	Year	Citations
Gemcitabine Plus Carboplatin Compared With Carboplatin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer: An Intergroup Trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG Jacobus Pfisterer, Marie Plante, Ignace Vergote, Journal of Clinical Oncology	2006	746
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms Philipp Harter, Jalid Sehouli, Domenica Lorusso, New England Journal of Medicine	2019	571
Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse Éric Pujade-Lauraine, Uwe Wagner, Elisabeth Aavall-Lundqvist, Journal of Clinical Oncology	2010	558
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004) Andreas du Bois, Michael Quinn, Tate Thigpen, Annals of Oncology MedicineCancer ManagementReproductive HealthGynecologyGcig Occc 2004	2005	465
Mixed‐polarization phenotype of ascites‐associated macrophages in human ovarian carcinoma: Correlation of CD163 expression, cytokine levels and early relapse Silke Reinartz, Tim Schumann, Florian Finkernagel, International Journal of Cancer Mixed‐polarization PhenotypeHuman Ovarian CarcinomaCancer ImmunosurveillanceMedicineImmunology	2013	280
Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer Volker Ziller, Matthias Kalder, Ute‐Susann Albert, Annals of Oncology Breast OncologyMedicineGynecologyEndocrine TherapyBreast Cancer	2009	258
Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro Christian M. Kurbacher, Uwe Wagner, Bernd Kolster, Cancer Letters Ascorbic AcidAntineoplastic ActivityBreast OncologyOncogenic AgentMedicine	1996	234
Single Particle Soot Photometer intercomparison at the AIDA chamber M. Laborde, Martin Schnaiter, Christian Linke, Atmospheric measurement techniques Environmental MonitoringEngineeringAir Pollution MeasurementMeasurementEducation	2012	210
Randomized Phase III Trial of Topotecan Following Carboplatin and Paclitaxel in First-line Treatment of Advanced Ovarian Cancer: A Gynecologic Cancer Intergroup Trial of the AGO-OVAR and GINECO Jacobus Pfisterer, B. Weber, Rainer Kimmig, JNCI Journal of the National Cancer Institute	2006	208
Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer. Andreas M. Kaufmann, Peter L. Stern, Elaine M. Rankin, PubMed	2002	204

Page 1